penny stock fortunes

Track Record Update 10/10/17

1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017

Our covered positions for the Newsletter Portfolio are below.
70% have been for GAINS of 50% or GREATER.

ENDOCYTE, INC. Closed position at $5.80 for a 152% GAIN.

CASI PHARMACEUTICALS. Closed position at $2.30 for a 64% GAIN.

BOVIE MEDICAL. Closed position at $3.82 for a 63% GAIN.

PALATIN TECHNOLOGIES. Closed position at 86¢ for a 50% GAIN.

CAREDX, INC. Closed position at $4.40 for an 83% GAIN.

VIKING THERAPEUTICS. Closed position at $1.82 for a 54% GAIN.

HARVARD BIOSCIENCES. Closed position at $3.88 for a 55% GAIN.

DICERNA PHARMACEUTICALS. Closed position at $5.26 for a 54% GAIN.

T2 BIOSYSTEMS, INC. Closed position at $6.85 for a 67% GAIN.

ATHERSYS, INC. Closed position at $2.23 for a 51% GAIN.

TRACON PHARMACEUTICALS. Closed position at $3.57 for a 55% GAIN.

INTERPACE DIAGNOSTICS. Closed position at $1.53 for 60% GAIN.

MARINUS PHARMACEUTICALS. Closed position at $2.40 for a 74% GAIN.

TANDEM DIABETES CARE. Closed position at $5.35 for a 72% LOSS.
(price reflects reverse stock split)

ALLIQUA BIOMEDICAL. Closed position at 36¢ for a 71% LOSS.

MEI PHARMA, INC. Closed position at $3.23 for a 73% GAIN.

REWALK ROBOTICS. Closed position at $1.81 for a 64% GAIN.

IMMUNOGEN, INC. Closed position at $6.88 for a 54% GAIN.

NAVIDEA BIOPHARMA. Closed position at 43¢ for an 78% LOSS.

BIOLASE. Closed position at 59¢ for an 81% LOSS.

AVEO PHARMACEUTICALS. Closed position at $2.20 for a 53% GAIN.

CARDIOME PHARMA. Closed position at $4.26 for a 55% GAIN.

ARBUTUS BIOPHARMA. Closed position at $3.74 for a 52% GAIN.

IPASS. Closed position at 62¢ for a 68% LOSS.

VERASTEM, INC. Closed position at $2.06 for a 62% GAIN.

SYNACOR, INC. Closed position at $4.24 for a 52% GAIN.

AMPLIPHI BIOSCIENCES. Closed position at 88¢ for a 90% LOSS.
(price reflects reverse stock split)

MOLECULAR TEMPLATES. Closed position at $5.25 for an 87% LOSS.
(price reflects reverse stock split).

HTG MOLECULAR DIAGNOSTICS. Closed position at $4.74 for a 63% GAIN.

QUARTERHILL. Closed position at $1.48 for a 2% GAIN.

PEREGRINE PHARMA. Closed position at $4.28 for a 63% LOSS.
(price reflects reverse stock split)

AURINIA PHARMACEUTICALS. Closed position at $5.50 for a 78% GAIN.

INTERNAP CORPORATION. Closed position at $3.39 for a 51% GAIN.

TONIC PHARMA. Closed position at $4.30 for a 79% LOSS.
(price reflects reverse stock split)

CELSION. Closed position at $2.25 for an 86% LOSS.
(price reflects reverse stock split)

PIERIS PHARMACEUTICALS. Closed position at $2.49 for a 54% GAIN.

SONOMA PHARMACEUTICALS. Closed position at $7.24 for a 52% GAIN.
(price reflects reverse stock split)

REXAHN PHARMACEUTICALS. Closed position at $3.00 for a 68% LOSS.
(price reflects reverse stock split)

ONCONOVA THERAPEUTICS. Closed position at $2.10 for a 91% LOSS.
(price reflects reverse stock split)

EYEGATE PHARMACEUTICALS. Closed position at $2.70 for a 65% GAIN.

ACTINIUM PHARMACEUTICALS. Closed position at $1.67 for a 67% GAIN.

ROSETTA GENOMICS. Closed position at $4.08 for an 88% LOSS.
(price reflects reverse stock split)

MAST THERAPEUTICS. Closed position at 12cent for an 80% LOSS.

GIGPEAK, INC. Closed position at $3.08 for a 45% GAIN.
(being acquired by IDT)

COMBIMATRIX CORPORATION. Closed position at $4.06 for a 53% GAIN.

CONATUS PHARMACEUTICALS. Closed position at $5.10 for a 126% GAIN.

MOSYS, INC. Closed position at $2.39 for an 88% LOSS.
(price reflects reverse stock split)

SIGNAL GENETICS. Closed position at $16.17 for a 25% LOSS.
(price reflects reverse stock split)

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.

Article source: http://pennystock.com/trackrecord.shtml

Be Sociable, Share!

Sorry, comments are closed for this post.